First real-world data on safety and effectiveness of glecaprevir/pibrentasvir for the treatment of patients with chronic hepatitis C virus infection: Data from the German Hepatitis C-Registry

First real-world data on safety and effectiveness of glecaprevir/pibrentasvir for the treatment of patients with chronic hepatitis C virus infection: Data from the German Hepatitis C-Registry

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Hepatology - Volume 68, Supplement 1, April 2018, Page S37

T. Berg, U. Naumann, A. Stoehr, C. Sick, G. Teuber, W. Schiffelholz, S. Mauss, J. Hettinger, H. Kleine, A. Pangerl, C. Niederau,